Vandetanib: An overview of its clinical development in NSCLC and other tumors.
Morabito A, Piccirillo MC, Costanzo R, Sandomenico C, Carillio G, Daniele G, Giordano P, Bryce J, Carotenuto P, La Rocca A, Di Maio M, Normanno N, Rocco G, Perrone F.
Morabito A, et al. Among authors: di maio m.
Drugs Today (Barc). 2010 Sep;46(9):683-98. doi: 10.1358/dot.2010.46.9.1516989.
Drugs Today (Barc). 2010.
PMID: 20967300
Review.